CompletedNCT00246246
Official study titleA Randomized, Open-label Trial of RISPERDAL® CONSTA™ Versus Oral Antipsychotic Care in Subjects With Bipolar Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18–65
- Countries
- Sponsor
- Janssen-Ortho Inc., Canada
CompletedNCT01202604
Official study titleProspective, Observational Study for the Maintenance Treatment of Patients With Bipolar Disorder I and II in Greece.
This study has finished and is no longer accepting participants.
Multiple locations, including AigioBipolarityObservational studyAges 18–65
- Countries
- Greece
- Sponsor
- AstraZeneca
CompletedNCT00094926
What is this study about?Researchers compared Risperdal Consta and placebo, tracking side effects to assess safety in adults with bipolarity.
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18–70
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT06273774
Official study titleA Multiple Dose Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-8189 in Participants With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockBipolarityMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
CompletedNCT00035230
What is this study about?This study evaluated the safety and effectiveness of Topiramate for people with bipolarity.
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 16+
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT00299715
Official study titleA Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Response, Multicenter Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone in the Treatment of Subjects With Acute Manic and Mixed Episodes Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18–65
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT00484471
Official study titleA Double Blind, Randomized, Placebo Controlled Trial of Aripiprazole Plus Valproate in the Short-Term and Long-Term Treatment of Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including TuenmenBipolarityMedication studyAges 18–65
- Countries
- China, Philippines, Taiwan, + 1 other
- Sponsor
- Korea Otsuka International Asia Arab
CompletedNCT01188265
Official study titleDextromethorphan Enhances the Therapeutic Efficacy of Valoproate in Bipolar Disorder Patients
This study has finished and is no longer accepting participants.
In TainanBipolarityMedication studyAges 18–65
- Countries
- Taiwan
- Sponsor
- National Cheng-Kung University Hospital